<!DOCTYPE html>
<html>
<head>
  <meta charset="utf-8">
  <title>Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses</title>
</head>
<body>
  <a href="../../index.html">← Back to home</a>
  <h1>Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses</h1>
  <ul>
<li>The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 mill</li>
<li>We intend to utilize a portion of the proceeds to fund our recently expanded share repurchase authorization." BioReference Health's continuing operations include its core clinical testing operations in the New York and N</li>
<li>15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc.</li>
<li>The purchase price for the transaction is up to $225 million, including $192.5 million that was paid at closing and up to $32.5 million in an earnout based on performance.</li>
<li>and MIAMI, Sept.</li>
<li>Piper Sandler &amp; Co.</li>
<li>Learn more about us at www.labcorp.com</li>
</ul>
<p><a href="https://finance.yahoo.com/news/labcorp-completes-acquisition-select-assets-123000533.html">Source</a> · 2025-09-15T12:30:00+00:00</p>
</body>
</html>